These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 39267958)

  • 1. Evaluation of good review practices in member authorities of the East African Medicines Regulatory Harmonisation initiative: strategies for alignment with African medicines agency.
    Ngum N; Ndomondo-Sigonda M; Habonimana R; Siyoi F; Irasabwa C; Ojukwu J; Apolinary F; Okello A; Ahmada S; Walker S; Salek S
    Front Med (Lausanne); 2024; 11():1437970. PubMed ID: 39267958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the review models and approval timelines of authorities participating in the East African Medicine Regulatory Harmonisation initiative: alignment and strategies for moving forward.
    Ngum N; Ndomondo-Sigonda M; Habonimana R; Siyoi F; Irasabwa C; Ojukwu J; Apolinary F; Okello A; Ahmada S; Walker S; Salek S
    Front Med (Lausanne); 2024; 11():1438041. PubMed ID: 39355848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Effectiveness and Efficiency of the East African Community Joint Assessment Procedure by Member Countries: The Way Forward.
    Ngum N; Mashingia J; Ndomondo-Sigonda M; Walker S; Salek S
    Front Pharmacol; 2022; 13():891506. PubMed ID: 35865962
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of the Good Review Practices of Countries Participating in the Southern African Development Community: Alignment and Strategies for Moving Forward.
    Sithole T; Mahlangu G; Capote V; Sitoie T; Shifotoka S; Gaeseb J; Padayachee S; Sehloho T; Khea A; Fimbo A; Munkombwe Z; Mwale B; Salek S; Walker S
    Front Med (Lausanne); 2021; 8():742181. PubMed ID: 34513893
    [No Abstract]   [Full Text] [Related]  

  • 5. Regional regulatory harmonisation initiatives: Their potential contribution to the newly established African Medicines Agency.
    Ngum N; Ndomondo-Sigonda M; Walker S; Salek S
    Regul Toxicol Pharmacol; 2023 Dec; 145():105497. PubMed ID: 37778434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Three Regional Medicines Regulatory Harmonisation Initiatives in Africa: Opportunities for Improvement and Alignment.
    Sithole T; Ngum N; Owusu-Asante M; Walker S; Salek S
    Int J Health Policy Manag; 2024; 13():8070. PubMed ID: 39099506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National medicines regulatory authorities financial sustainability in the East African Community.
    Ndomondo-Sigonda M; Miot J; Naidoo S; Ng'andu B; Ngum N; Masota NE; Kaale E
    PLoS One; 2020; 15(7):e0236332. PubMed ID: 32702048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Best practices in the African Medicines Regulatory Harmonization initiative: Perspectives of regulators and medicines manufacturers.
    Ndomondo-Sigonda M; Azatyan S; Doerr P; Agaba C; Harper KN
    PLOS Glob Public Health; 2023; 3(4):e0001651. PubMed ID: 37186241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What makes joint assessment procedures attractive to the innovative industry: successes, challenges, and proposed improvements.
    Miletic N; Adam S; Acquah J; Aziz Z; Joos A; Mwangi JM
    Front Med (Lausanne); 2023; 10():1207954. PubMed ID: 37731723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the effectiveness and efficiency of the East African community joint assessment procedure by pharmaceutical companies: Opportunities for improvement.
    Ngum N; Mashingia J; Ndomondo-Sigonda M; Walker S; Salek S
    Front Pharmacol; 2022; 13():1031289. PubMed ID: 36408267
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulatory performance of the East African Community joint assessment procedure: The way forward for regulatory systems strengthening.
    Mashingia J; Ngum N; Ndomondo-Sigonda M; Kermad A; Bujar M; Salek S; Walker S
    Regul Toxicol Pharmacol; 2023 May; 140():105383. PubMed ID: 36933643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The domestication of the African Union model law on medical products regulation: Perceived benefits, enabling factors, and challenges.
    Ncube BM; Dube A; Ward K
    Front Med (Lausanne); 2023; 10():1117439. PubMed ID: 36793874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The South African Medicines Control Council: Comparison of Its Registration Process With Australia, Canada, Singapore, and Switzerland.
    Keyter A; Salek S; Banoo S; Walker S
    Front Pharmacol; 2019; 10():228. PubMed ID: 30923501
    [No Abstract]   [Full Text] [Related]  

  • 14. The process of ratifying the treaty to establish the African Medicines Agency: perspectives of national regulatory agencies.
    Ncube BM; Dube A; Ward K
    Health Policy Plan; 2024 May; 39(5):447-456. PubMed ID: 38497780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Review Models and Approval Timelines of Countries Participating in the Southern African Development Community: Alignment and Strategies for Moving Forward.
    Sithole T; Mahlangu G; Capote V; Sitoie T; Shifotoka S; Gaeseb J; Danks L; Nkambule P; Juma A; Fimbo A; Munkombwe Z; Mwale B; Salek S; Walker S
    Front Med (Lausanne); 2021; 8():742200. PubMed ID: 34513894
    [No Abstract]   [Full Text] [Related]  

  • 16. Medicines Regulatory Science Expertise in Africa: Workforce Capacity Development and Harmonisation Activities Towards the Establishment of the African Medicines Agency.
    Ncube BM; Dube A; Ward K
    Pharmaceut Med; 2022 Apr; 36(2):83-97. PubMed ID: 35380413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of the African Medicines Agency: progress, challenges and regulatory readiness.
    Ncube BM; Dube A; Ward K
    J Pharm Policy Pract; 2021 Mar; 14(1):29. PubMed ID: 33685518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of regulatory requirements on medicine registration in African countries - perceptions and experiences of pharmaceutical companies in South Africa.
    Narsai K; Williams A; Mantel-Teeuwisse AK
    South Med Rev; 2012 Jul; 5(1):31-7. PubMed ID: 23093897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the effectiveness and efficiency of the economic community of West African States Medicines Regulatory Harmonization initiative by the pharmaceutical industry.
    Owusu-Asante M; Darko DM; Walker S; Salek S
    Front Pharmacol; 2023; 14():1184108. PubMed ID: 37229251
    [No Abstract]   [Full Text] [Related]  

  • 20. Collaborative reliance in medicine safety and quality regulation: Investigation of experiences in handling N-nitrosamine impurities among ZaZiBoNa participating countries.
    Shabangu PP; Kuwana RJ; Dube A
    Front Med (Lausanne); 2022; 9():975032. PubMed ID: 36160156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.